Diabetes and Risk of Post-Fragility Hip Fracture Outcomes in Elderly Patients. (14th April 2020)

• Record Type: Journal Article
• Authors: Tian, Wenqing; Wu, Jueli; Tong, Tao; Zhang, Lu; Zhou, Aiguo; Hu, Ning; Huang, Wei; Zhou, Bo
• Other Names: Reimondo Giuseppe Academic Editor.
• Is Part Of: International journal of endocrinology. Volume 2020(2020)
• Publication Date: 2020-04-14
• Subjects: Endocrinology -- Periodicals; Endocrinology; Endocrinology -- Periodicals; Endocrine System Diseases -- Periodicals; Periodicals; 616.4
• DOI: 10.1155/2020/8146196
• Languages: English
• ISSNs: 1687-8337

Abstract

Abstract : Objective . To explore the effect of diabetes on short-term (30 days after fracture) and 1-year outcomes for fragility hip fracture patients. Methods . We conducted a retrospective cohort study involving 161 diabetic hip fracture patients (older than 60 years) and 483 nondiabetic hip fracture patients. Patients were followed up on day 30 and 1 year after fracture. The short-term outcome was complications that occurred within 30 days after hip fracture and length of stay. The 1-year outcomes were postfracture functional outcomes and reduced activity level and mortality rate within 1 year after fracture. The clinical characteristics and outcomes of patients were analyzed. Results . Compared with nondiabetic patients, diabetic patients had a longer length of awaiting surgery (6.0 vs. 5.0 days, P = 0.031 ) and a longer length of total hospital stay (17 vs. 15 days, P < 0.001 ). Furthermore, compared with nondiabetic patients, diabetic patients have higher costs (P = 0.011 ), in addition to being more prone to developing urinary tract infections (6.2% vs. 1.7%, P = 0.002 ) and deep vein thrombosis (4.3% vs. 1.4%, P = 0.029 ) complications. However, at one-year follow-up, no differences in recovery of function and mortality were observed between the two groups. Conclusions . Diabetic patients are at an increased risk of urinary tract infections and deep vein thrombosis complications but have similar recovery of function and 1-year mortality compared to nondiabetic patients.